| Cisplatin binding to human serum albumin: a structural study G Ferraro, L Massai, L Messori, A Merlino Chemical communications 51 (46), 9436-9439, 2015 | 141 | 2015 |
| Determinants for tight and selective binding of a medicinal dicarbene gold (I) complex to a telomeric DNA G‐quadruplex: a joint ESI MS and XRD investigation C Bazzicalupi, M Ferraroni, F Papi, L Massai, B Bertrand, L Messori, ... Angewandte Chemie 128 (13), 4328-4331, 2016 | 107 | 2016 |
| Chemistry and biology of two novel gold (I) carbene complexes as prospective anticancer agents L Messori, L Marchetti, L Massai, F Scaletti, A Guerri, I Landini, S Nobili, ... Inorganic Chemistry 53 (5), 2396-2403, 2014 | 97 | 2014 |
| The mode of action of anticancer gold-based drugs: a structural perspective L Messori, F Scaletti, L Massai, MA Cinellu, C Gabbiani, A Vergara, ... Chemical communications 49 (86), 10100-10102, 2013 | 81 | 2013 |
| Replacement of the thiosugar of auranofin with iodide enhances the anticancer potency in a mouse model of ovarian cancer T Marzo, L Massai, A Pratesi, M Stefanini, D Cirri, F Magherini, M Becatti, ... ACS Medicinal Chemistry Letters 10 (4), 656-660, 2019 | 66 | 2019 |
| Design, synthesis and characterisation of new chimeric ruthenium (II)–gold (I) complexes as improved cytotoxic agents L Massai, J Fernández-Gallardo, A Guerri, A Arcangeli, S Pillozzi, ... Dalton Transactions 44 (24), 11067-11076, 2015 | 64 | 2015 |
| Cytotoxic properties of a new organometallic platinum (II) complex and its gold (I) heterobimetallic derivatives M Serratrice, L Maiore, A Zucca, S Stoccoro, I Landini, E Mini, L Massai, ... Dalton Transactions 45 (2), 579-590, 2016 | 59 | 2016 |
| Antiproliferative effects of two gold (I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study F Magherini, T Fiaschi, E Valocchia, M Becatti, A Pratesi, T Marzo, ... Oncotarget 9 (46), 28042, 2018 | 58 | 2018 |
| Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme C Gabbiani, L Massai, F Scaletti, E Michelucci, L Maiore, MA Cinellu, ... JBIC Journal of Biological Inorganic Chemistry 17, 1293-1302, 2012 | 57 | 2012 |
| Size dependent biological profiles of PEGylated gold nanorods F Tatini, I Landini, F Scaletti, L Massai, S Centi, F Ratto, S Nobili, ... Journal of materials chemistry B 2 (36), 6072-6080, 2014 | 54 | 2014 |
| Interaction of anticancer Ru (III) complexes with single stranded and duplex DNA model systems D Musumeci, L Rozza, A Merlino, L Paduano, T Marzo, L Massai, ... Dalton Transactions 44 (31), 13914-13925, 2015 | 52 | 2015 |
| Interactions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(iii) compound L Messori, F Scaletti, L Massai, MA Cinellu, I Russo Krauss, G Di Martino, ... Metallomics 6 (2), 233-236, 2014 | 51 | 2014 |
| Selection and characterization of a human ovarian cancer cell line resistant to auranofin I Landini, A Lapucci, A Pratesi, L Massai, C Napoli, G Perrone, P Pinzani, ... Oncotarget 8 (56), 96062, 2017 | 50 | 2017 |
| A nitric oxide/Ca2+/calmodulin/ERK1/2 mitogen‐activated protein kinase pathway is involved in the mitogenic effect of IL‐1β in human astrocytoma cells A Meini, C Sticozzi, L Massai, M Palmi British journal of pharmacology 153 (8), 1706-1717, 2008 | 48 | 2008 |
| Reactions of medicinal gold (III) compounds with proteins and peptides explored by electrospray ionization mass spectrometry and complementary biophysical methods L Massai, C Zoppi, D Cirri, A Pratesi, L Messori Frontiers in Chemistry 8, 581648, 2020 | 46 | 2020 |
| Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold (III) compound Aubipyc T Gamberi, L Massai, F Magherini, I Landini, T Fiaschi, F Scaletti, ... Journal of Proteomics 103, 103-120, 2014 | 46 | 2014 |
| Platinum (II) complexes with O, S bidentate ligands: biophysical characterization, antiproliferative activity, and crystallographic evidence of protein binding C Mügge, T Marzo, L Massai, J Hildebrandt, G Ferraro, ... Inorganic Chemistry 54 (17), 8560-8570, 2015 | 42 | 2015 |
| Chemistry and biology of three representative gold (III) compounds as prospective anticancer agents C Gabbiani, MA Cinellu, L Maiore, L Massai, F Scaletti, L Messori Inorganica Chimica Acta 393, 115-124, 2012 | 37 | 2012 |
| Medicinal gold compounds form tight adducts with the copper chaperone Atox-1: biological and pharmacological implications C Gabbiani, F Scaletti, L Massai, E Michelucci, MA Cinellu, L Messori Chemical communications 48 (95), 11623-11625, 2012 | 37 | 2012 |
| Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties I Landini, L Massai, D Cirri, T Gamberi, P Paoli, L Messori, E Mini, S Nobili Journal of Inorganic Biochemistry 208, 111079, 2020 | 35 | 2020 |
